| Hepatitis C History |
Intercurrent Conditions |
| Likely year of acquisition:
Acquisition
|
Diabetes:
Diabetes
|
| Year of chronic hepatitis C Diagnosis:
Chronic Hep C
|
Obesity (BMI>30):
BMI
|
| Known Cirrhosis*:
Cirrhosis
|
Immunosuppressed:
Immuno
|
| Hepatic Decompensation (ascites, encephalopathy, variceal bleeding)*:
Hepatic Decomp
|
Hepatitis B*:
Hep B
|
| Any previous treatment with Direct Acting Antivirals for HCV:
Direct Antivirals
|
HIV*:
HIV
|
| * If ANY apply, please refer to a specialist for clinical review |
Alcohol >40g/day:
Alcohol
|
| LABS (OR ATTACH COPY OF RESULTS |
| Test |
Result |
Date |
Test |
Result |
Date |
| HCV Genotype: |
HCV Genotype
|
HCV
|
INR: |
INR
|
INR
|
| Viral Load: |
Viral Load
|
Viral
|
Creatinine: |
Creatinine
|
Creatinine
|
| ALT: |
ALT
|
ALT
|
eGFR: |
eGFR
|
eGFR
|
| AST: |
AST
|
AST
|
Hb: |
Hb Result
|
Hb Result
|
| Total Bilibrubin: |
Total Bilbrubin
|
Bilbrubin
|
Platelets: |
Platelets
|
Platelets
|
| Albumin: |
Albumin
|
Albumin
|
ß HCG: |
B HCG
|
B HCG
|
| DRUG INTERACTIONS AND COUNSELLING |
| I have entered current medication (prescription and over-the-counter) and proposed treatment regimen according to genotype into
http://www.hep-druginteractions.org/
and assessed outputs. Recommend printing and attaching the outputs.
NB: Current GP practice software is NOT sufficient for assessing these potential drug interactions. Complementary and alternative medicines should already be ceased and therefore not entered.
|
Yes o No o On no Medication o
|
| Amiodarone at any time in last 3 months: |
Yes o No o |
| *If hep-drug interactions chart RED or AMBER please await specialist response |
| Cease ALL non-traditional (complementary and alternative) medicines during treatment: |
Yes o No o N/A o
|
| Contraception education given (males and females): |
Yes o No o N/A o |
| Management of this patient will be according to Australian Recommendations for the Management of HCV infection consensus statement 2016 https://www.asid.net.au/documents/item/1208 |
Yes o No o |
| HCV INTENDED TREATMENT REGIMEN (for patients with NO CIRRHOSIS) |
| Regimen |
Genotype |
Duration |
Please tick |
| Sofosbuvir + ledipasvir |
1 |
8 weeks |
o |
|
1 |
12 weeks |
o |
| Sofosbuvir + daclatasvir |
1 |
12 weeks |
o |
|
3 |
12 weeks |
o |
| Sofosbuvir + ribavirin |
2 |
12 weeks |
o |
| Paritaprevir + ritonavir + ombitasvir + dasabuvir |
1b |
12 weeks |
o |
| Paritaprevir + ritonavir + ombitasvir + dasabuvir + ribavirin |
1a |
12 weeks |
o |
Monitoring of patients on treament - see https://www.asid.net.au/documents/item/1208, https://melbourne.healthpathways.org.au, https://www.hepvic.org.au/
Alcohol and other drugs (AOD Support ) - see http://www.directline.org.au/, http://www.vaada.org.au/wp-content/uploads/2014/09/VIC-AOD-Catchment-Intake-and-Assessment-details.pdf and
https://www2.health.vic.gov.au/alcohol-and-drugs/aod-treatment-services/pathways-into-aod-treatment/aod-telephone-online-services